Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Silencing miR-21-5p in sensory neurons reverses neuropathic allodynia via activation of TGF-β–related pathway in macrophages
Lynda Zeboudj, … , David Chambers, Marzia Malcangio
Lynda Zeboudj, … , David Chambers, Marzia Malcangio
Published April 18, 2023
Citation Information: J Clin Invest. 2023;133(11):e164472. https://doi.org/10.1172/JCI164472.
View: Text | PDF
Research Article Immunology Neuroscience

Silencing miR-21-5p in sensory neurons reverses neuropathic allodynia via activation of TGF-β–related pathway in macrophages

  • Text
  • PDF
Abstract

Neuropathic pain remains poorly managed by current therapies, highlighting the need to improve our knowledge of chronic pain mechanisms. In neuropathic pain models, dorsal root ganglia (DRG) nociceptive neurons transfer miR-21 packaged in extracellular vesicles to macrophages that promote a proinflammatory phenotype and contribute to allodynia. Here we show that miR-21 conditional deletion in DRG neurons was coupled with lack of upregulation of chemokine CCL2 after nerve injury and reduced accumulation of CCR2-expressing macrophages, which showed TGF-β–related pathway activation and acquired an M2-like antinociceptive phenotype. Indeed, neuropathic allodynia was attenuated after conditional knockout of miR-21 and restored by TGF-βR inhibitor (SB431542) administration. Since TGF-βR2 and TGF-β1 are known miR-21 targets, we suggest that miR-21 transfer from injured neurons to macrophages maintains a proinflammatory phenotype via suppression of such an antiinflammatory pathway. These data support miR-21 inhibition as a possible approach to maintain polarization of DRG macrophages at an M2-like state and attenuate neuropathic pain.

Authors

Lynda Zeboudj, George Sideris-Lampretsas, Rita Silva, Sabeha Al-Mudaris, Francesca Picco, Sarah Fox, David Chambers, Marzia Malcangio

×

Figure 2

miR-21 silencing induces an antiinflammatory phenotype and upregulates TGF-β–related pathway in macrophages.

Options: View larger image (or click on image) Download as PowerPoint
miR-21 silencing induces an antiinflammatory phenotype and upregulates T...
Macrophages transfected with an miR-21 antagomir (antagomir-21) or scramble control followed by RT-qPCR and flow cytometry. (A) miR-21-5p fold change in BMDMs after 48-hour transfection with antagomir-21 (n = 8). (B) Spry2 mRNA fold change in BMDMs after 48-hour transfection with antagomir-21 (n = 8). (C) Tgfb1 fold change in BMDMs after transfection with antagomir-21, n = 8 per group pooled from 2 independent experiments. (D) Spearman’s correlation between miR-21-5p expression and Tgfb1 mRNA expression (n = 11). (E) RT-qPCR of Tgfbr2, Tgfbr1, Tgfbr3, and Smad7 in BMDMs after 48-hour transfection with antagomir-21 (n = 8). (F) RT-qPCR of proinflammatory genes Tnfa and Il6 in BMDMs transfected with antagomir-21 (n = 8). (G) RT-qPCR of antiinflammatory genes Mrc1 and Il10, n = 8 per group, pooled from 2 independent experiments. (H) Flow cytometry analysis of TGF-βR2 expression in BMDMs after silencing miR-21-5p, n = 4 per group. The bar graphs represent the percentage of F4/80+TGF-βR2+ cells. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01 by unpaired, 2-tailed Student’s t test (A–C and E–G).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts